Buy, Hold, or Sell: Why Everyone Is Wrong About Amazon’s Secret Bet

Photo of Alex Sirois
By Alex Sirois Published

Quick Read

  • AWS holds a $364 billion revenue backlog growing at 28%, its fastest clip in 15 quarters, while trailing free cash flow collapsed nearly to zero.

  • AMZN sits roughly 12% below its 52-week high, but analysts rate it a Buy with a consensus target near $313 implying 25% upside.

  • Andy Jassy projects Trainium at scale will save tens of billions in annual capex and add hundreds of basis points of operating margin advantage.

  • This lithium producer surpassed a $1B private valuation, joining some of America’s most powerful startups. Now you can invest in EnergyX alongside global giants like General Motors, but only through July 16. (sponsor)

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Buy, Hold, or Sell: Why Everyone Is Wrong About Amazon’s Secret Bet

© A hand holding a tablet displaying a graph arrow soaring upwards, representing growth, against a digital world map backdrop (Shutterstock.com) by Who is Danny

At $247.04, Amazon (NASDAQ:AMZN | AMZN Price Prediction) looks compelling on a risk/reward basis. The market’s fixation on near-term cash outlays obscures a $364 billion contracted revenue backlog. The stock trades below its 50-day moving average of $254.60 even as management commits to the largest cloud infrastructure buildout in company history.

AWS has become the primary earnings engine. It grew $150 billion annualized business growing 28%, its fastest pace in 15 quarters, and custom silicon (Trainium, Graviton, Nitro) crossed $20 billion revenue run rate with triple-digit year-over-year growth.

The tension is real: Q1 2026 EPS of $2.78 topped consensus expectations by a wide margin, yet capex hit $44.203 billion in a single quarter and trailing-twelve-month free cash flow collapsed 95% to $1.2 billion. Investors are repricing that tradeoff now.

The Bull Case: $364 Billion in Contracted Demand

AWS reported a $364 billion revenue backlog in Q1, excluding the $100 billion+ Anthropic deal and $225 billion in Trainium revenue commitments already booked. OpenAI is committed to roughly 2 GW of Trainium capacity starting 2027, Anthropic to up to 5 GW, and Meta to tens of millions of Graviton cores.

Custom silicon drives the margin story. Trainium2 is largely sold out, Trainium3 nearly fully subscribed. CEO Andy Jassy told analysts Trainium at scale will “save us tens of billions of dollars of CapEx each year and provide several hundred basis points of operating margin advantage.”. Analysts back the setup: 62 of 66 covering analysts rate the stock a Buy or Strong Buy, with a consensus target of $312.91.

The Bear Case: $200 Billion Spent, Returns Uncertain

Amazon plans to spend roughly $200 billion in capex in 2026. Long-term debt climbed from $65.6 billion to $119.1 billion, interest expense jumped from $541 million to $800 million, and AWS operating margin compressed from 39.5% to 37.7% despite growth acceleration.

Insiders have sold. 75 recent insider transactions show a net selling direction, an unusual signal against the analyst chorus. Polymarket assigns just 29.5% probability that AMZN closes above $250 by end of July. The thesis may be right and still leave the stock dead money for quarters.

The Hold Case: Right Story, Wrong Entry

Shares trade roughly 12% below the 52-week high of $278.56, with prediction markets clustering July outcomes around $256. Limited near-term catalyst exists until Q2 earnings.

Patient investors could wait for three signals: free cash flow re-acceleration, Trainium3 revenue flowing through the P&L, or a tech drawdown resetting entry closer to $232 level prediction markets assign a 48% probability. If Q2 lands at the top of the $194 to $199 billion revenue guide, a rerating tightens quickly.

Valuation and Positioning

Amazon trades at $247.04, up 1.4% on the session and 1.8% over the past week. Year-to-date the stock is up 7.03%, trailing the S&P 500’s 10.23% YTD gain. Over one year AMZN is up 11.01% versus the index’s 20.45%.

The stock trades at trailing P/E of 32 and forward P/E of 31, with an EV/EBITDA of 15. The $312.91 consensus target across 66 analysts implies roughly 25% upside.

Options positioning skews bullish with a full-chain put/call ratio of 0.35. Reddit sentiment swung from bearish in late June to bullish through early July.

The Verdict: Constructive at $247

At $247.04, the risk/reward on Amazon looks constructive.

The path to appreciation is mechanical. AWS carries a $364 billion backlog against $37.587 billion quarterly AWS run. As Trainium3 shipments ramp and Anthropic and OpenAI capacity come online in 2027, revenue growth outpaces capex growth. Jassy said “free cash flow and ROIC for these investments are cumulatively quite attractive.”. For readers modeling infrastructure buildout, our AI infrastructure report separates durable capex from wasted spend.

The next two quarters will look ugly on free cash flow, explaining the current valuation. But the 74.8% YoY earnings growth, expanding North America margins (7.9% from 6.3%), and Q1 operating margin of 13.1%, the highest ever, show the base business absorbing the buildout.

Invalidation triggers: AWS growth slipping below 20%, backlog conversion slowing, or a customer walking away from a multi-gigawatt commitment. None are visible in current filings. Insider selling and the FCF collapse are real risks, but at anywhere at or below $245, the risk/reward tilts toward the buyer of contracted future revenue.

Contact [email protected] for any questions or corrections.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Continue Reading

Top Gaining Stocks

META Vol: 40,258,435
KMX Vol: 2,270,340
WY Vol: 6,426,154
SBAC Vol: 1,440,388
NVDA Vol: 147,043,407

Top Losing Stocks

MRNA Vol: 9,136,481
CTRA Vol: 73,319,495
CRWD Vol: 8,128,993
DDOG Vol: 3,567,720
EPAM Vol: 1,164,474